Latest Biotech News

The pulsed field ablation (PFA) modality for cardiac arrhythmia treatment continues its rapid ascent with major funding rounds and clinical advancement. Field Medical Inc. secured an additional...

Multiple studies highlight the complex interplay between climatic shifts and infectious diseases. Rising temperatures and altered weather patterns facilitate expansion of vector-borne diseases...

The biotechnology sector experiences mixed fortunes as the BioWorld Cancer Index rebounded 12.78% in Q2 following Q1 losses, while the Nasdaq Biotechnology Index narrowed its decline to 1.92%....

The FDA granted accelerated approval to Dizal Pharmaceutical’s sunvozertinib (Zegfrovy) for adults with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20 insertion...

Leading institutions and companies are leveraging artificial intelligence to revolutionize biotech R&D and healthcare. Google DeepMind unveiled AlphaGenome, a unified AI model predicting diverse...

Recent studies unveil promising molecular targets and therapies shaping oncology. Regeneron secured FDA approval for bispecific Lynozyfic in multiple myeloma with improved dosing flexibility. New...

Groundbreaking investigations reveal new insights into neural regeneration, brain development, and neurodegeneration. Novel evidence confirms adult neurogenesis and stem cell precursors in the...

Innovations spanning sustainable manufacturing and environmental health emerge prominently. Arsenale Bioyards pioneers neo-industrial biomanufacturing platform integrating AI and modular...

Rapid progress in diagnostic methodology and precision medicine is reshaping healthcare. Spatial biology and multiomics provide unprecedented tumor microenvironment insights, aiding personalized...

Researchers have pioneered innovative stem cell technologies to enhance tissue repair and regeneration. Aligned mesenchymal stem cell sheets significantly amplify therapeutic protein secretion....

Groundbreaking molecular and genomic research is yielding new drug targets and therapeutic approaches across cancer types. Studies reveal EMP1 as a prognostic driver in pancreatic cancer, and...

Recent regulatory decisions and industry trends reflect evolving dynamics in biotech. The U.S. court has halted sweeping HHS layoffs deemed likely unlawful, impacting agencies including FDA and...

Key studies illuminate global health and environmental concerns with biotech implications. Air pollution and traditional herbal medicine exposures are linked to lung cancer in never-smokers, while...

Dr. Divita Mathur of Case Western Reserve University has secured an NSF CAREER grant to advance synthetic DNA nanoparticles' design and intracellular behavior. This research promises significant...

The FDA granted accelerated approval to Dizal Pharmaceutical's sunvozertinib (Zegfrovy) for non-small-cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations, marking a targeted oral...

Recent studies highlight significant progress in cancer immunotherapy and tumor biology. A phase 2 trial demonstrated dual TIGIT and PD-1 blockade enhances survival in hepatocellular carcinoma,...

Artificial intelligence is increasingly integral to biotech innovation and healthcare delivery. Google's AlphaGenome model unifies multimodal genomic predictions enhancing variant effect...

Groundbreaking studies have deepened understanding of neurodegenerative diseases and brain physiology. New evidence confirms ongoing neurogenesis in adult human brains, identifying active neural...

Innovative approaches in stem cell science promise to transform regenerative therapies. Researchers engineered aligned mesenchymal stem cell sheets, significantly boosting protein secretion...

Spatial biology and multiomics integration are revolutionizing cancer research by elucidating tumor heterogeneity and microenvironmental interactions. Techniques mapping gene and protein...